Showing results (1511-1520 of 3,569) with videos related to
Sort By:
Pageof 357
Journal of Thrombosis and Thrombolysis|August 14, 2014
Thromboembolic complications in inflammatory bowel diseaseDarina Kohoutova, Paula Moravkova, Peter Kruzliak, et al.Journal of Thrombosis and Thrombolysis|August 7, 2014
Impact of aspirin resistance on outcomes among patients following coronary artery bypass grafting: exploratory analysis from randomized controlled trial (NCT01159639)Mate Petricevic, Tomislav Kopjar, Hrvoje Gasparovic, et al.Journal of Thrombosis and Thrombolysis|December 30, 2011
Body composition, C-reactive protein, carotid artery remodeling and subclinical atherosclerosis in a general Taiwanese populationJui-Peng Tsai, Helen L Po, Chih-Hsuan Yen, et al.Journal of Thrombosis and Thrombolysis|January 10, 2013
Increased local cytokine production at culprit superficial femoral artery plaquesCameron W Donaldson, David J Schneider, Daniel J Bertges, et al.Journal of Thrombosis and Thrombolysis|December 18, 2012
The comparison of EPC count and function in the situation of vascular repair at early and late stageGuohou He, Hongmei Zhang, Xiaodong Zhang, et al.Journal of Thrombosis and Thrombolysis|December 18, 2012
Maintaining a minimally invasive approach-vascular closure after trans-catheter aortic valve interventionJames Cockburn, Adam de Belder, Mike Lewis, et al.Journal of Thrombosis and Thrombolysis|December 19, 2012
Socioeconomic factors and concomitant diseases are related to the risk for venous thromboembolism during long time follow-upNazim Isma, Juan Merlo, Henrik Ohlsson, et al.Journal of Thrombosis and Thrombolysis|December 25, 2012
Urinary prothrombin fragment 1+2 in patients with venous thrombosis and myocardial infarctionJ van Es, S Biere-Rafi, M Ahdi, et al.Journal of Thrombosis and Thrombolysis|June 2, 2012
Atopaxar and its effects on markers of platelet activation and inflammation: results from the LANCELOT CAD programMichelle L O'Donoghue, Deepak L Bhatt, Marcus D Flather, et al.Journal of Thrombosis and Thrombolysis|December 6, 2012
Relationship between biomarkers and subsequent bleeding risk in ST-segment elevation myocardial infarction patients treated with paclitaxel-eluting stents: a HORIZONS-AMI substudyWouter J Kikkert, Bimmer E Claessen, Gregg W Stone, et al.Pageof 357